(Q71752197)
Statements
Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies (English)
Tu SM
Hossan E
Amato R
Kilbourn R
1 November 1995
scientific article published on 01 November 1995